OS by p53 status, hormone receptor status, nuclear grade, and pCR
. | No. of patients . | No. of events . | 5-year OS . | . | P . | |
---|---|---|---|---|---|---|
. | . | . | Estimate . | 95% CI . | . | |
All patients | ||||||
p53 negative | 20 | 10 | 54% | 35–82 | ||
p53 positive | 28 | 16 | 44% | 27–70 | 0.4 | |
Hormone receptor negative | ||||||
p53 negative | 9 | 5 | 56% | 31–100 | ||
p53 positive | 21 | 13 | 38% | 21–69 | ||
Hormone receptor positive | ||||||
p53 negative | 10 | 5 | 48% | 25–94 | ||
p53 positive | 5 | 2 | 75% | 43–100 | 0.73 | |
Nuclear grade 2 | ||||||
p53 negative | 7 | 3 | 57% | 30–100 | ||
p53 positive | 4 | 1 | 67% | 30–100 | ||
Nuclear grade 3 | ||||||
p53 negative | 11 | 6 | 53% | 30–94 | ||
p53 positive | 23 | 15 | 37% | 21–67 | 0.51 | |
No pCR | ||||||
p53 negative | 16 | 41% | 22–76 | |||
p53 positive | 23 | 40% | 23–68 | |||
pCR | ||||||
p53 negative | 4 | |||||
p53 positive | 5 | 67% | 30–100 | 0.51 |
. | No. of patients . | No. of events . | 5-year OS . | . | P . | |
---|---|---|---|---|---|---|
. | . | . | Estimate . | 95% CI . | . | |
All patients | ||||||
p53 negative | 20 | 10 | 54% | 35–82 | ||
p53 positive | 28 | 16 | 44% | 27–70 | 0.4 | |
Hormone receptor negative | ||||||
p53 negative | 9 | 5 | 56% | 31–100 | ||
p53 positive | 21 | 13 | 38% | 21–69 | ||
Hormone receptor positive | ||||||
p53 negative | 10 | 5 | 48% | 25–94 | ||
p53 positive | 5 | 2 | 75% | 43–100 | 0.73 | |
Nuclear grade 2 | ||||||
p53 negative | 7 | 3 | 57% | 30–100 | ||
p53 positive | 4 | 1 | 67% | 30–100 | ||
Nuclear grade 3 | ||||||
p53 negative | 11 | 6 | 53% | 30–94 | ||
p53 positive | 23 | 15 | 37% | 21–67 | 0.51 | |
No pCR | ||||||
p53 negative | 16 | 41% | 22–76 | |||
p53 positive | 23 | 40% | 23–68 | |||
pCR | ||||||
p53 negative | 4 | |||||
p53 positive | 5 | 67% | 30–100 | 0.51 |
Abbreviation: CI, confidence interval.